Half of children given new weight-loss drug are no longer clinically obese, study finds

“The efficacy of [the weight-loss drug] semaglutide is a true game-changer for the medical treatment of obesity, a chronic disease that shortens life through its many complications," commented Professor Nick Finer (UCL Institute of Cardiovascular Science).

Read: Evening Standard